The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients
dc.contributor.author | Ozgen, A. G. | |
dc.contributor.author | Karadeniz, M. | |
dc.contributor.author | Erdogan, M. | |
dc.contributor.author | Berdeli, A. | |
dc.contributor.author | Saygili, F. | |
dc.contributor.author | Yilmaz, C. | |
dc.date.accessioned | 2019-10-27T20:51:36Z | |
dc.date.available | 2019-10-27T20:51:36Z | |
dc.date.issued | 2009 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Introduction: Interleukins and cytokines play an important role in the pathogenesis of many cancers. We aimed to evaluate the interleukin (IL)-6 gene polymorphisms in patients with papillary thyroid carcinoma (PTC) and control subjects. Material and methods: In this study, 42 patients with PTC and 340 healthy controls were included. Peripheral blood samples were taken from control group and patients, and blood samples were preserved at -80 C in tubes containing Na-EDTA. Results: We also found a statistically significant difference between patients with PTC and the control group with respect to IL-6 genotype (p<0.05). IL-6 gene polymorphism in patients with PTC patients did not reveal statistically significant difference between the 2 groups (size of tumor >1 cm and <1 cm), multicentricity, RET-PTC types and capsule invasion (p>0.05). We also did not find a statistically significant difference between patients with PTC and the control group with respect to IL-6-gene allele frequency (p>0.05). Discussion: Our data suggest that the IL-6 G-174 C polymorphism could play a role in thyroid cancer risk, but there is no effective role as a prognostic factor. (J. Endocrinol. Invest. 32: 491-494, 2009) (C) 2009, Editrice Kurtis | en_US |
dc.identifier.doi | 10.3275/6184 | en_US |
dc.identifier.endpage | 494 | en_US |
dc.identifier.issn | 1720-8386 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 19494710 | en_US |
dc.identifier.startpage | 491 | en_US |
dc.identifier.uri | https://doi.org/10.3275/6184 | |
dc.identifier.uri | https://hdl.handle.net/11454/43130 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000271594800002 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Journal of Endocrinological Investigation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | (-174) G/C polymorphismin | en_US |
dc.subject | interleukin-6 gene | en_US |
dc.subject | papillary thyroid carcinoma | en_US |
dc.title | The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients | en_US |
dc.type | Article | en_US |